Review article: alginate-raft formulations in the treatment of heartburn and acid reflux.
about
Interventions for heartburn in pregnancyPharmacological treatment of children with gastro-oesophageal refluxInterventions for heartburn in pregnancyPharmacological treatment for gastro-oesophageal reflux in childrenAdverse effects reported in the use of gastroesophageal reflux disease treatments in children: a 10 years literature reviewImprovement in survival after paraquat ingestion following introduction of a new formulation in Sri LankaCurrent progress on bio-based polymers and their future trendsEvidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.Omeprazole-Domperidone Fixed Dose Combination vs Omeprazole Monotherapy: A Phase 4, Open-Label, Comparative, Parallel Randomized Controlled Study in Mild to Moderate Gastroesophageal Reflux DiseaseProspective, randomized, and active controlled study of the efficacy of alginic acid and antacid in the treatment of patients with endoscopy-negative reflux disease.Alginate in drug delivery systems.Gaviscon® vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial.Effect of Gaviscon Infant on gastro-oesophageal reflux in infants assessed by combined intraluminal impedance/pHAlginate therapy is effective treatment for gastroesophageal reflux disease symptoms: a systematic review and meta-analysis.Alginate controls heartburn in patients with erosive and nonerosive reflux diseaseAlginate as a source of dietary fiber.An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial 'acid pocket' in symptomatic GERD patientsThe Proton Pump Inhibitor Non-Responder: A Clinical ConundrumRandomised clinical trial: the clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in ChinaEfficacy of alginate-based reflux suppressant and magnesium-aluminium antacid gel for treatment of heartburn in pregnancy: a randomized double-blind controlled trial.Laryngopharyngeal reflux: Current concepts in pathophysiology, diagnosis, and treatment.NERD: an umbrella term including heterogeneous subpopulations.Current pharmacological management of gastroesophageal reflux disease.Effect of alginate in patients with GERD hiatal hernia matters.Between GERD and NERD: the relevance of weakly acidic reflux.Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease.Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis.Randomised clinical trial: sodium alginate oral suspension is non-inferior to omeprazole in the treatment of patients with non-erosive gastroesophageal disease.Efficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease: a randomized clinical trial.Alginate-antacid combinations: raft formation and gastric retention studies.Formulation and optimisation of raft-forming chewable tablets containing H2 antagonist.Raft Formation of Sodium Alginate in the Stomach.Distinction between patients with non-erosive reflux disease and functional heartburn.Effect of sodium alginate on acid gastroesophageal reflux disease in preterm infants: a pilot study.Proton pump inhibitors reduce the size and acidity of the gastric Acid pocket.Echo-planar magnetic resonance imaging of Gaviscon alginate rafts in-vivo.An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH-metry.Post-prandial reflux suppression by a raft-forming alginate (Gaviscon Advance) compared to a simple antacid documented by magnetic resonance imaging and pH-impedance monitoring: mechanistic assessment in healthy volunteers and randomised, controlledRaft-forming agents: antireflux formulations.Re‐evaluation of alginic acid and its sodium, potassium, ammonium and calcium salts (E 400–E 404) as food additives
P2860
Q24187104-74417605-15E8-456A-8C27-86D8C2E42248Q24187847-CA28D9E4-CDEF-4148-839E-98C47FD4E43AQ24188284-3E3E3332-7FA4-46D6-852A-BD3F4D523652Q24235056-10BFC351-2EF2-47C8-A4E3-EB1D4F10FFCFQ28082238-8FA5514F-6624-463E-A41F-7B9CA8EB942FQ28472237-BEF5C814-BC8B-412A-A953-0AB1B7D5F9BCQ28588012-CB391DB9-9631-481F-9F35-DF9E3664E692Q30249468-572F0E9F-C1C9-49F6-B88B-2B323AE1E5E7Q30854493-43247B56-5CDB-4680-9A62-7ED2020A6E69Q33788450-FA816970-2401-419F-9542-590BD8B44B67Q34141966-425483A6-97B9-42D5-A6BD-29E5658CC6C0Q34169062-4B38A461-71E5-464B-9D07-49325E3B1574Q35283587-567ADFC7-335E-4876-BA8E-2F0DAF0C1A90Q36145570-25ACF2A9-DB70-4B08-8E37-67990A79478EQ36215537-5172A6C7-4698-460A-9510-8AA7DEA59C82Q36267675-2B120E0B-3C30-4B81-B3E3-04272452221BQ36730470-F248DE07-6F95-4D4C-8DD7-2BDB8BA12062Q36752080-EA12A12F-956C-40A8-8346-1F9CF951684FQ37295956-C7F72521-F591-4CC5-9D7D-4957ED066AFEQ37710702-E47FC20C-255C-4B29-94C4-C0A184039E80Q37788702-B7EF8F4B-1632-42FD-BB39-CA341B88C5BCQ38092939-DEB0AD01-3AAF-4F60-8320-E114A8185105Q38123482-BC36FB81-B3BD-4AD0-8078-7324AE93C085Q38599589-A9DB6A4C-43E3-4D9F-8F90-10A5C69B8490Q38912494-6FDB9C12-D7C8-4B61-9787-BCE6DFB23215Q39212872-728F9BC3-7076-4428-A579-39A1E9CB5664Q39218829-42173FF6-4D3D-4369-A3D2-C6F85B9634C0Q39220802-1BA500C0-2BEF-4B42-B20A-B4EF9A9FD2CEQ39256826-92D4DE09-BB97-4ABA-8830-37C661E1DC86Q39280716-D59C5408-5588-492D-AAA1-8ECF170B525CQ39649956-4FAEFB4C-BB3D-4631-809D-D15273095ABEQ41382818-1A2BBFDB-4D26-422F-B811-E9CAA6574131Q42406587-E3448132-86D1-4F90-9DAF-EF591E97A2B5Q43057930-60FB2086-D172-4D53-9A9A-165C4AE12BE1Q43097594-735F4A03-9674-41EB-9E13-BCFF60195A8EQ44191435-34570AEF-38D6-4FFB-9966-31037FB77D42Q45219627-80C124A6-08FC-4101-BFBB-41B99FB3047AQ45835157-68902A01-7869-451D-829D-CCE1C3A2C8D8Q46837633-6BBF6657-7073-476F-AE86-914FB323347DQ47161008-1362F5F9-8D58-426B-9C2A-A1B8EF5EE033
P2860
Review article: alginate-raft formulations in the treatment of heartburn and acid reflux.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Review article: alginate-raft formulations in the treatment of heartburn and acid reflux.
@ast
Review article: alginate-raft formulations in the treatment of heartburn and acid reflux.
@en
type
label
Review article: alginate-raft formulations in the treatment of heartburn and acid reflux.
@ast
Review article: alginate-raft formulations in the treatment of heartburn and acid reflux.
@en
prefLabel
Review article: alginate-raft formulations in the treatment of heartburn and acid reflux.
@ast
Review article: alginate-raft formulations in the treatment of heartburn and acid reflux.
@en
P2093
P2860
P1476
Review article: alginate-raft formulations in the treatment of heartburn and acid reflux.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2036.2000.00759.X
P407
P577
2000-06-01T00:00:00Z